FDA Investigator Cynthia L Evitt
Cynthia L Evitt has conducted inspections on 24 sites in 3 countries as of 16 Aug 2004. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
24
Last Inspection Date:
16 Aug 2004
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Belgium,
France
FDA Investigators that have inspected at least one site in common with Cynthia L Evitt:
Aisha N Rashad,
Amy E Devine,
Anthony R Bucks,
Aref Mel Demerdash,
Barbara I Rogolsky,
Bonnie E Pierson,
Brenda C Hamilton,
Brett R Havranek,
Brittany D Terhar,
Carl A Huffman, III,
Carl J Montgomery,
Chilton L Ng,
Chris A Sack,
Cody D Rickman,
Cynthia M Goudeau,
Danial S Hutchison,
Daniel R Hurt,
Dr. Abhijit Raha, PhD,
Eric C Fox,
Eric C Nielsen,
Eric M Mueller, PharmD,
Farhana Khan,
George Ivan Wey,
Gwyn G Dickinson,
Humberto Z Gomez,
Ingrid Y Johnson,
James D Planchon,
Jane E Nelson,
Jeannie M Vonderbrink,
Jeffrey W Shrifter, DPM,
Jessica E Hensley,
Jessica L Peterson,
Jonathan R Campos,
Joseph R Lambert,
Jyoti B Patel, PhD,
Kathleen B Swat,
Kellia N Hicks,
Latonya M Mitchell,
LCDR Ismael Olvera, IV,
LCDR Matthew J Morrison,
LCDR Matthew R Mcnew, MPH, REHS/RS,
Linda R Kuchenthal,
Lisa L Gilliam,
Lori A Gioia,
Marie K Kinkade,
Marion D Wimberly, Jr,
Mark S Ross,
Matthew R Sleeter,
Megan M Kirk,
Michael F Skelly, PhD,
Michael S Smoker,
Michele L Obert,
Michele Perry Williams,
Minerva Rogers,
Mohsen Rajabi Abhari, FDA,
Neal L Adams,
Nicole J Conklin,
Nilufer M Tampal, PhD,
Pamela L Velez Vega,
Patrick L Wisor,
Rachel Collen,
Raymond Valdivia,
Rebecca Rodriguez,
Robin K Hatfield,
Robin K Reel,
Rodney D Combs,
Shelley H Beausoleil,
Shirley J Berryman,
Stuart W Russell,
Susanna E Ford,
Tara L Greene,
Tara L King,
Thomas W Gordon,
Torrey M Ward,
Vickie J Kanion,
Victoria A Wagoner,
Warren J Lopicka,
Xikui Chen (nmi), PhD,
Yiyue Zhang (nmi), PhD,
Zachary A Bogorad
Cynthia L Evitt's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2002 | EIR | Dujovne, Dr Carlos - EIR, 2002-04-16 |
August, 2001 | FDA 483 | Nostrum Laboratories, Inc. - Form 483, 2001-08-29 |
August, 2004 | FDA 483 | Celerion, Inc - Form 483, 2004-08-20 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more